Judge Denies Compounder’s Motion to Dismiss Allergan’s False Advertising Complaint

Drug Industry Daily
A A
A federal judge refused to dismiss a false advertising lawsuit filed by Allergan against drug compounder Imprimis Pharmaceuticals concerning its dry-eye drug Klarity, meant to compete with Allergan’s Restasis.

To View This Article:

Login

Subscribe To Drug Industry Daily